Elizabeth Egan appointed President of Havas Lynx Group

News

Europe’s largest healthcare communications agency has appointed a new President to help it build on a record year.

Elizabeth Egan will oversee the continued expansion of Havas Lynx Group in the EU, using her extensive experience in global leadership roles at AstraZeneca and Weight Watchers to support the company’s commitment to changing the way the world does healthcare communications for the better.

Elizabeth joined the network 12 months ago and has played a key role in the growth of Havas Lynx London and has enjoyed significant successes with Roche and Janssen, with the focus now on delivering global campaign development, brand strategy and healthcare innovation.

The appointment comes after CEO David Hunt decided to head stateside to oversee the expansion of Havas Health & You (HH&Y) on the West Coast.

David will initially be supporting the San Francisco team and managing key regional clients, before launching a new offering for the network in Los Angeles.

His move comes after a successful 15-year career with Havas Lynx Group, playing a crucial role in the transformation of a small creative agency in the Northern Quarter of Manchester into a globally recognised healthcare communications specialist, employing 400 people and representing blue chip accounts, including AstraZeneca, Janssen and Novartis.

Elizabeth Egan commented, “David has been a huge driving force for Havas Lynx Group over the past 15 years and I’m excited to take up the challenge of moving the agency to the next stage.

“Working at Havas Lynx London has given me the opportunity to understand the ethos of the business and the passion we have for provoking conversation in the healthcare sector. Over the last eighteen months we have also created a senior leadership team that will ensure it is business in usual in Europe.”

Havas Lynx Group’s recent growth has been achieved by blending strategic insight and deep scientific understanding with creativity and digital innovation to deliver maximum impact healthcare campaigns and solutions.

This approach has seen it secure a string of new contracts that has boosted annual fees and helped to create 50 new jobs in the first part of 2019. It has also launched Havas Lynx Faze, a specialist clinical trial recruitment agency that focuses on helping clients design a better trial experience for patients.

Elizabeth concluded: “Havas Lynx in the UK is in very good health. The Senior Leadership Team has been in development for almost two years, with many of them having spent almost a decade learning the essence of Creative Lynx.”